Numerous likely pathogenic/pathogenic loss of function (LoF) germline variants were observed in ERCC3, with rs145201970 (n = 42) representing the second most observed LoF variant in this gene in cancer patients after rs34295337 (n = 70) [46]. The gene discussed is ERCC3; the disease is cancer.